aluates Reports

$ 0.0

Automative

Japanese Encephalitis Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-13W12321

Global Japanese Encephalitis Virus Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Japanese Encephalitis Virus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13W12321

Report

September 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Research Foundation for Microbial Diseases of Osaka University

Valneva Austria GmbH

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

Japanese Encephalitis Virus Vaccine - Market Size

The global market for Japanese Encephalitis Virus Vaccine was estimated to be worth US$ 408.6 million in 2023 and is forecast to a readjusted size of US$ 572.2 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Japanese Encephalitis Virus Vaccine - Market

Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Virus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Japanese Encephalitis Virus Vaccine by region & country, by Type, and by Application.

The Japanese Encephalitis Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Virus Vaccine.

Market Segmentation

Scope of Japanese Encephalitis Virus Vaccine - Market Report

Report Metric	Details
Report Name	Japanese Encephalitis Virus Vaccine - Market
Forecasted market size in 2030	US$ 572.2 million
CAGR	5.3%
Forecasted years	2024 - 2030
Segment by Type:	Inactivated Vaccine Live Attenuated Vaccine
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, Wuhan Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Japanese Encephalitis Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Japanese Encephalitis Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Japanese Encephalitis Virus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Japanese Encephalitis Virus Vaccine - Market size in 2030?

Ans: The Japanese Encephalitis Virus Vaccine - Market size in 2030 will be US$ 572.2 million.

Who are the main players in the Japanese Encephalitis Virus Vaccine - Market report?

Ans: The main players in the Japanese Encephalitis Virus Vaccine - Market are Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, Wuhan Institute

What are the Application segmentation covered in the Japanese Encephalitis Virus Vaccine - Market report?

Ans: The Applications covered in the Japanese Encephalitis Virus Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Japanese Encephalitis Virus Vaccine - Market report?

Ans: The Types covered in the Japanese Encephalitis Virus Vaccine - Market report are Inactivated Vaccine, Live Attenuated Vaccine

1 Market Overview

1.1 Japanese Encephalitis Virus Vaccine Product Introduction

1.2 Global Japanese Encephalitis Virus Vaccine Market Size Forecast

1.2.1 Global Japanese Encephalitis Virus Vaccine Sales Value (2019-2030)

1.2.2 Global Japanese Encephalitis Virus Vaccine Sales Volume (2019-2030)

1.2.3 Global Japanese Encephalitis Virus Vaccine Sales Price (2019-2030)

1.3 Japanese Encephalitis Virus Vaccine Market Trends & Drivers

1.3.1 Japanese Encephalitis Virus Vaccine Industry Trends

1.3.2 Japanese Encephalitis Virus Vaccine Market Drivers & Opportunity

1.3.3 Japanese Encephalitis Virus Vaccine Market Challenges

1.3.4 Japanese Encephalitis Virus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Japanese Encephalitis Virus Vaccine Players Revenue Ranking (2023)

2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Company (2019-2024)

2.3 Global Japanese Encephalitis Virus Vaccine Players Sales Volume Ranking (2023)

2.4 Global Japanese Encephalitis Virus Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Japanese Encephalitis Virus Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Japanese Encephalitis Virus Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Japanese Encephalitis Virus Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Japanese Encephalitis Virus Vaccine

2.9 Japanese Encephalitis Virus Vaccine Market Competitive Analysis

2.9.1 Japanese Encephalitis Virus Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Japanese Encephalitis Virus Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Inactivated Vaccine

3.1.2 Live Attenuated Vaccine

3.2 Global Japanese Encephalitis Virus Vaccine Sales Value by Type

3.2.1 Global Japanese Encephalitis Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Japanese Encephalitis Virus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Japanese Encephalitis Virus Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Japanese Encephalitis Virus Vaccine Sales Volume by Type

3.3.1 Global Japanese Encephalitis Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Japanese Encephalitis Virus Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Japanese Encephalitis Virus Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Japanese Encephalitis Virus Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Japanese Encephalitis Virus Vaccine Sales Value by Application

4.2.1 Global Japanese Encephalitis Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Japanese Encephalitis Virus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Japanese Encephalitis Virus Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Japanese Encephalitis Virus Vaccine Sales Volume by Application

4.3.1 Global Japanese Encephalitis Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Japanese Encephalitis Virus Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Japanese Encephalitis Virus Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Japanese Encephalitis Virus Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Japanese Encephalitis Virus Vaccine Sales Value by Region

5.1.1 Global Japanese Encephalitis Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Japanese Encephalitis Virus Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Japanese Encephalitis Virus Vaccine Sales Volume by Region

5.2.1 Global Japanese Encephalitis Virus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Japanese Encephalitis Virus Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

5.4.2 North America Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

5.5.2 Europe Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

5.7.2 South America Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value

6.2.1 Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.3.2 United States Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.4.2 Europe Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.5.2 China Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.6.2 Japan Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Japanese Encephalitis Virus Vaccine Sales Value, 2019-2030

6.9.2 India Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Japanese Encephalitis Virus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Research Foundation for Microbial Diseases of Osaka University

7.1.1 Research Foundation for Microbial Diseases of Osaka University Company Information

7.1.2 Research Foundation for Microbial Diseases of Osaka University Introduction and Business Overview

7.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Offerings

7.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Development

7.2 Valneva Austria GmbH

7.2.1 Valneva Austria GmbH Company Information

7.2.2 Valneva Austria GmbH Introduction and Business Overview

7.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Offerings

7.2.5 Valneva Austria GmbH Recent Development

7.3 Chengdu Institute

7.3.1 Chengdu Institute Company Information

7.3.2 Chengdu Institute Introduction and Business Overview

7.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Offerings

7.3.5 Chengdu Institute Recent Development

7.4 Liaoning Dacheng

7.4.1 Liaoning Dacheng Company Information

7.4.2 Liaoning Dacheng Introduction and Business Overview

7.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Offerings

7.4.5 Liaoning Dacheng Recent Development

7.5 Wuhan Institute

7.5.1 Wuhan Institute Company Information

7.5.2 Wuhan Institute Introduction and Business Overview

7.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Offerings

7.5.5 Wuhan Institute Recent Development

8 Industry Chain Analysis

8.1 Japanese Encephalitis Virus Vaccine Industrial Chain

8.2 Japanese Encephalitis Virus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Japanese Encephalitis Virus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Japanese Encephalitis Virus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Research Foundation for Microbial Diseases of Osaka University

Valneva Austria GmbH

Chengdu Institute

Liaoning Dacheng

Wuhan Institute

List of Tables

Table 1. Japanese Encephalitis Virus Vaccine Market Trends

Table 2. Japanese Encephalitis Virus Vaccine Market Drivers & Opportunity

Table 3. Japanese Encephalitis Virus Vaccine Market Challenges

Table 4. Japanese Encephalitis Virus Vaccine Market Restraints

Table 5. Global Japanese Encephalitis Virus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Japanese Encephalitis Virus Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Japanese Encephalitis Virus Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Japanese Encephalitis Virus Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Japanese Encephalitis Virus Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Japanese Encephalitis Virus Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Japanese Encephalitis Virus Vaccine

Table 13. Global Japanese Encephalitis Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Japanese Encephalitis Virus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Japanese Encephalitis Virus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Japanese Encephalitis Virus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Japanese Encephalitis Virus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Japanese Encephalitis Virus Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Japanese Encephalitis Virus Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Japanese Encephalitis Virus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Japanese Encephalitis Virus Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Japanese Encephalitis Virus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Japanese Encephalitis Virus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Japanese Encephalitis Virus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Japanese Encephalitis Virus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Japanese Encephalitis Virus Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Japanese Encephalitis Virus Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Japanese Encephalitis Virus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Japanese Encephalitis Virus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Japanese Encephalitis Virus Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Japanese Encephalitis Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Japanese Encephalitis Virus Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Japanese Encephalitis Virus Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Japanese Encephalitis Virus Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Japanese Encephalitis Virus Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Research Foundation for Microbial Diseases of Osaka University Company Information

Table 58. Research Foundation for Microbial Diseases of Osaka University Introduction and Business Overview

Table 59. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Offerings

Table 61. Research Foundation for Microbial Diseases of Osaka University Recent Development

Table 62. Valneva Austria GmbH Company Information

Table 63. Valneva Austria GmbH Introduction and Business Overview

Table 64. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Offerings

Table 66. Valneva Austria GmbH Recent Development

Table 67. Chengdu Institute Company Information

Table 68. Chengdu Institute Introduction and Business Overview

Table 69. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Offerings

Table 71. Chengdu Institute Recent Development

Table 72. Liaoning Dacheng Company Information

Table 73. Liaoning Dacheng Introduction and Business Overview

Table 74. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Offerings

Table 76. Liaoning Dacheng Recent Development

Table 77. Wuhan Institute Company Information

Table 78. Wuhan Institute Introduction and Business Overview

Table 79. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Offerings

Table 81. Wuhan Institute Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Japanese Encephalitis Virus Vaccine Downstream Customers

Table 85. Japanese Encephalitis Virus Vaccine Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Japanese Encephalitis Virus Vaccine Product Picture

Figure 2. Global Japanese Encephalitis Virus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Japanese Encephalitis Virus Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Japanese Encephalitis Virus Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Japanese Encephalitis Virus Vaccine Report Years Considered

Figure 7. Global Japanese Encephalitis Virus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Japanese Encephalitis Virus Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Japanese Encephalitis Virus Vaccine Revenue in 2023

Figure 10. Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Inactivated Vaccine Picture

Figure 12. Live Attenuated Vaccine Picture

Figure 13. Global Japanese Encephalitis Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Japanese Encephalitis Virus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Japanese Encephalitis Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Japanese Encephalitis Virus Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Japanese Encephalitis Virus Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Japanese Encephalitis Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Japanese Encephalitis Virus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Japanese Encephalitis Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Japanese Encephalitis Virus Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Japanese Encephalitis Virus Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Japanese Encephalitis Virus Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Japanese Encephalitis Virus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Japanese Encephalitis Virus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Japanese Encephalitis Virus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Japanese Encephalitis Virus Vaccine Industrial Chain

Figure 59. Japanese Encephalitis Virus Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions